A novel PET radiotracer, [18F]-1-deoxy-1-fluoro-scyllo-inositol, was synthesized via a one-pot reaction in 16 +/- 3% uncorrected radiochemical yield within 80 minutes; although this compound revealed low brain penetration it shows promise in rodent tumour models for breast cancer imaging.
To identify a lead skeleton structure for optimization of scyllo-inositol-based inhibitors of amyloid-beta peptide (Aβ) aggregation, we have synthesized aldoxime, hydroxamate, carbamate, and amide linked scyllo-inositol derivatives. These structures represent backbones that can be readily expanded into a wide array of derivatives. They also provide conservative modifications of the scyllo-inositol backbone, as they maintain the display of the equatorial polar atoms, preserving the stereochemical requirement necessary for maximum inhibition of Aβ(1-42) fiber formation. In addition, a reliable work plan for screening derivatives was developed in order to preferentially identify a backbone(s) structure that prevents fibrillogenesis and stabilizes nontoxic small molecular weight oligomers, as we have previously reported for scyllo-inositol. In the present studies, we have adapted a high throughput ELISA-based oligomerization assay followed by atomic force microscopy to validate the results screen compounds. The lead compounds were then tested for toxicity and ability to rescue Aβ(1-42) induced toxicity in vitro and the affinity of the compounds for Aβ(1-42) compared by mass spectrometry. The data to suggest that compounds must maintain a planar conformation to exhibit activity similar to scyllo-inositol and that the oxime derivative represents the lead backbone for future development. KEYWORDS: Amyloid-beta peptide, fibrillogenesis, medicinal chemistry, atomic force microscopy, mass spectrometry scyllo-Inositol, a potential therapeutic compound for Alzheimer's disease, has been shown to inhibit Aβ(1-42) fibrillogenesis in vitro, 1 stabilize cell-derived small molecular weight oligomers, 2 reduce amyloid plaque load and neuroinflammation, and ameliorate cognitive deficits in vivo. 2,3 These combined studies demonstrated that scyllo-inositol stabilizes low molecular weight oligomers of Aβ that are nontoxic and readily removed from and/or degraded within the central nervous system. scyllo-Inositol is the most potent inositol, with a single epimerization to form myo-inositol yielding a less active compound in vivo and in vitro, suggesting that efficacy is highly dependent on inhibitor stereochemistry. 3 scyllo-Inositolinduced changes to the peptide assembly of Aβ(1-42) are very sensitive to structural perturbations of scyllo-inositol such as the number and orientation of the hydroxyl groups. 2 These structure− function studies revealed that even the most conservative single hydroxyl substitution led to a decrease in compound potency with only 1-deoxy-1-fluoro-scyllo-inositol retaining properties similar to the parent scyllo-inositol. 4
Introduction-Organic Anion Transporting Polypeptides (OATP) are a family of membrane associated transporters that facilitate estrone-3-sulphate (E3S) uptake by hormone dependent, post-menopausal breast cancers. We have established E3S as a potential ligand for targeting hormone dependent breast cancer cells, and in this study sought to prepare and investigate radioiodinated E3S as a tool to study the OATP system. Methods-2-and 4-Iodoestrone-3-sulfates were prepared from estrone via aromatic iodination followed by a rapid and high yielding sulfation procedure. The resulting isomers were separated by preparative HPLC and verified by 1 H NMR and analytical HPLC. Transport studies of 2-and 4-[ 125 I]-E3S were conducted in hormone dependent (i.e. MCF-7) and hormone independent (i.e. MDA-MB-231) breast cancer cells in the presence or absence of the specific transport inhibitor, bromosulfophthalein (BSP). Cellular localization of OATP1A2, OATP2B1, OATP3A1 and OATP4A1 were determined by immunofluorescence analysis using anti-Na + /K + ATPase-α (1:100 dilution) and DAPI as plasma membrane and nuclear markers, respectively.
Results-Significantly
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.